1Angus D, Wax R. Epidemiology of sepsis: an update [ J ]. Crit Care Med,2001,29(7 suppl) :109 -116.
2Marshall J, Foster D, Vincent J, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study [ J ]. J Infect Dis,2004,190 ( 3 ) :527 - 534,
4Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents[J]. Ann Intern Med,1984,101 ( 1 ) :92 - 104.
5Hanasawa K,Tani T, Kodama M, et al. New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber [J].Surg Gyncol Obster,1989,168(4) :323 -331.
6Ronco C. The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis [ J ]. Crit Care, 2005,9 (6) :631 -633.
7Dinna NC, Mark AP, Rinaldo B, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review [ J ]. Crit Care,2007,11 (2) :47.
8Ueno T,Sugino M,Nemoto H,et al. Effect over time of endotoxin adsorption therapy in sepsis [ J ]. Ther Apher Dial, 2005,9 ( 2 ) : 128 - 136.
9Ono S,Tsujinomoto H, Matsumoto A, et al. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with polymyxin B-immobilized fiber [ J ]. Am J Surg, 2004,188(2) :150 - 156.
10Kojika M, Sato N, Yaegashi Y, et al. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX):evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity [ J ]. Ther Apher Dial ,2006,10 ( 1 ) : 12 - 18.
同被引文献14
1DAVIES B, COHEN J. Endotoxin removal devices for thetreatment of sepsis and septic shock [J]. Lancet Infect Dis,2011, 11(1): 65-71.
2WINTERS B D,EBERLEIN M, LEUNG J, et al. Long-term mortality and quality of life in sepsis: a systematic re-view CJ]. Crit Care Med,2010,38(5) : 1276-1283.
3ONG KG, LELAND J M,ZENGKF,et al. A rapid highly-sensitive endotoxin detection system [J]. Biosensors and Bio-electronics, 2006, 21(12): 2270-2274.
4MITAKA C,TOMITA M. Polymyxin B-immobilized fibercolumn hemoperfusion therapy for septic shock [J]. Shock,2011, 36(4): 332-338.
5PETSCH D, ANSPACH F B. Endotoxin removal from pro-tein solutions [J]. Biotechnology, 2000,76(2-3) : 97-119.
6SCHROMM A B, BRANDENBURG K,LOPPNOW H, etal. Biological activities of lipopolysaccharides are determinedby the shape of their lipid A portion [J]. Biochemistry, 2000,267(7): 2008-2013.
7CRUZ D N,PERAZELLA M A,BELLOMO R, et al. Effec-tiveness of polymyxin B-immobilized fiber column in sepsis : asystematic review [J]. Crit Care, 2007, 11(2) ; R47.
8ASANO T,KINOSHITA Y, KOBAYASHI M, et al. Bloodcompatibility of the adsorptive device filled with poly arylatebeads [J]. Biomed Mater Eng, 2010,20(1) : 47-54.
9TANI T, SHOJI H, GUADAGNI G, et al. Extracorporealremoval of endotoxin : the polymyxin B-immobilized fiber car-tridge [J]. Contrib Nephrol, 2010, 167(1): 35-44.
10HIRAYAMA C, SAKATA M, NAKAMURA M, et al.Preparation of poly( epsilon-lysine) adsorbents and applicationto selective removal of lipopolysaccharides [J]. J ChromatogrB Biomed Sci Appl, 1999, 721(2): 187-195.
